Synopsis of recent research by authors named "Alevtina Pavlenco"
Alevtina Pavlenco's recent research focuses on the development of engineered antibodies and fragments with enhanced stability and efficacy, particularly in the context of viral diseases such as COVID-19 and Marburg virus.
Her work includes the design of tetravalent neutralizing antibodies that demonstrate increased potency against SARS-CoV-2 and the identification of modifications that improve the crystallizability of antigen-binding fragments.
Additionally, Pavlenco's studies explore the use of peptide-antibody fusions and targeted synthetic antibodies to address specific viral mutations and contribute to novel therapeutic strategies.